Clinical Trial Update: A Study to Confirm the Efficacy and Safety of Fludarabine Phosphate Administered in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or Thrombocytopenia [Phase 4]

View source ↗

Summary

The Phase 4 study evaluating fludarabine phosphate in untreated chronic lymphocytic leukemia patients with anemia and/or thrombocytopenia has completed, reporti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Fludarabine phosphate (Fludarabine phosphate)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Leukemia, Lymphocytic, Chronic, B-Cell | Phase 4 | Status: COMPLETED